CJC/IPA (No DAC)

Product Description

CJC-1295 (No DAC) / Ipamorelin is a synergistic research peptide blend combining two of the most studied growth hormone secretagogues available. This combination is designed to stimulate the pituitary gland's natural release of growth hormone through complementary mechanisms — making it a subject of significant interest in peptide research. CJC-1295 (No DAC) is a modified form of Growth Hormone Releasing Hormone (GHRH). Without the Drug Affinity Complex (DAC), it produces a shorter, more pulsatile release of growth hormone, closely mimicking the body's natural secretion patterns. This makes it particularly valuable in studies examining physiological GH pulsatility. Ipamorelin is a selective Growth Hormone Releasing Peptide (GHRP) and ghrelin mimetic. It is widely recognized in research settings for its high selectivity and favorable tolerability profile, stimulating GH release with minimal impact on cortisol or prolactin levels — a key distinction from other GHRPs. When used together, CJC-1295 (No DAC) and Ipamorelin work via two distinct but complementary receptor pathways, producing a synergistic amplification of GH pulse amplitude and frequency. This dual-action mechanism has made the combination one of the most referenced peptide pairings in growth hormone secretagogue research. Each vial contains: 5mg CJC-1295 (No DAC) / 5mg Ipamorelin At Medvinci Research, we are committed to supplying research-grade peptides with verified purity. All products are manufactured under strict quality control standards and come with a Certificate of Analysis (COA) available for verification. This product is intended for research purposes only and is not intended for human use.